(4-chlorophenylamino)methylenediphosphonic acid

ID: ALA2440579

PubChem CID: 15629940

Max Phase: Preclinical

Molecular Formula: C7H10ClNO6P2

Molecular Weight: 301.56

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=P(O)(O)C(Nc1ccc(Cl)cc1)P(=O)(O)O

Standard InChI:  InChI=1S/C7H10ClNO6P2/c8-5-1-3-6(4-2-5)9-7(16(10,11)12)17(13,14)15/h1-4,7,9H,(H2,10,11,12)(H2,13,14,15)

Standard InChI Key:  PPOZCMYPJMEBPT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 17  0  0  0  0  0  0  0  0999 V2000
   18.5308   -3.0988    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   18.9420   -3.8050    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3480   -3.0957    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2339   -1.8704    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   19.6451   -2.5765    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0510   -1.8673    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6986   -2.2906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6974   -3.1101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4055   -3.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1151   -3.1096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1123   -2.2870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4037   -1.8817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8185   -1.8757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.5277   -2.2816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8246   -3.5101    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2308   -1.0532    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9894   -3.5181    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  5  4  1  0
  4  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 11 13  1  0
 13 14  1  0
 14  4  1  0
 14  1  1  0
  1 15  2  0
  4 16  2  0
  8 17  1  0
M  END

Alternative Forms

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hydroxyapatite (165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP14 Tchem Matrix metalloproteinase 14 (1592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP8 Tchem Matrix metalloproteinase 8 (1942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PROC1 Pyrroline-5-carboxylate reductase (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLN2 Glutamine synthetase, chloroplastic (68 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 301.56Molecular Weight (Monoisotopic): 300.9672AlogP: 1.39#Rotatable Bonds: 4
Polar Surface Area: 127.09Molecular Species: ACIDHBA: 3HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 0.95CX Basic pKa: CX LogP: 0.63CX LogD: -4.19
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.53Np Likeness Score: -0.66

References

1. Forlani G, Occhipinti A, Berlicki L, Dziedzioła G, Wieczorek A, Kafarski P..  (2008)  Tailoring the structure of aminobisphosphonates to target plant P5C reductase.,  56  (9): [PMID:18399639] [10.1021/jf800029t]
2. Occhipinti A, Berlicki Ł, Giberti S, Dziedzioła G, Kafarski P, Forlani G..  (2010)  Effectiveness and mode of action of phosphonate inhibitors of plant glutamine synthetase.,  66  (1): [PMID:19697446] [10.1002/ps.1830]
3. Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P..  (2013)  Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,  21  (21): [PMID:24071448] [10.1016/j.bmc.2013.08.054]

Source